HOME > ARCHIVE
ARCHIVE
- Sales of Micardis Expected to Jump 30% in 2005: Dr Banchi of BI
April 18, 2005
- The 109th Annual Meeting of Japan Ophthalmological Society
April 18, 2005
- Kibanken Starts Up with Staff of 95
April 18, 2005
- Kyoto Univ. Hospital to Beef Up New Drug Development
April 18, 2005
- Huma Aims to Boost Registered Volunteers to 500,000
April 18, 2005
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
April 18, 2005
- BUSINESS NEWS IN BRIEF
April 18, 2005
- The Reporter's Eye: 6
April 18, 2005
- Service Provider
April 18, 2005
- OTC & HEALTH FOODS
April 18, 2005
- 2005 Will Be Remembered as Major Turning Point for Domestic Drug Industry
April 18, 2005
- 11 Organizations Registered to Certify In Vitro Diagnostics, Med. Devices
April 18, 2005
- BUSINESS FORECASTS
April 18, 2005
- Pfizer Supports Women in Stopping Smoking without Gaining Weight
April 18, 2005
- BUSINESS RESULTS
April 18, 2005
- DIAGNOSTIC NEWS IN BRIEF
April 18, 2005
- Reporter's Eye: 5
April 18, 2005
- MEDICAL DEVICE NEWS IN BRIEF
April 18, 2005
- NEW PRODUCTS
April 18, 2005
- Tanabe Seiyaku Working to Strengthen Quality Assurance System
April 18, 2005
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
